EmailHospital Circular 17/2006
Date Issued: 4 September 2006
Publication: 17/2006
Distribution: Public Hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals of further changes to the Highly Specialised Drugs Program, effective 1 August 2006.
We have had recent advice from the Commonwealth Government of further changes to the Highly Specialised Drugs Program, effective 1 August 2006.
Price Decrease
Doxorubicin Hydrochloride, Pegylated Liposomal |
|||||
| 6249X | Suspension for I.V. infusion 20mg in 10ml vial | 1 | $622.99 | Caelyx | SH |
Lea Pope
Acting Director, Programs
Metropolitan Health & Aged Care Services
